Sort
21,281 grants matching “influenza”
CD8+ tissue-resident immunity to primary and heterotypic Influenza A controlled by commensal microbiota
$39,693Joseph Jacob Stevens · Cincinnati Childrens Hosp Med Ctr · F30 · FY2022 · HL
Combustion Generated Particulate Pollution Affects Infant Respiratory Health
$39,682Stephania A Cormier · Lsu Health Sciences Center · R01 · FY2013 · ES
CRYSTALLOGRAPHIC STUDY OF INFLUENZA B VIRUS HEMAGGLUTININ
$39,639Qinghua Wang · University Of Chicago · P41 · FY2006 · RR
Investigating the role of HSC70 AMPylation on nuclear localization and chaperone function
$39,603Shannon Marie Lacy · University Of Michigan At Ann Arbor · F31 · FY2023 · HL
Virus-Like Particle Vaccines for Pandemic Influenza
$39,590Ted M Ross · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
BIOPHYSICS OF INFLUENZA HEMAGGLUTININ-MEDIATED FUSION
$39,556Rush University Medical Center · R03 · FY2000 · TW
BIOPHYSICS OF INFLUENZA HEMAGGLUTININ-MEDIATED FUSION
$39,556Rush University Medical Center · R03 · FY2001 · TW
Antigen processing and the age-related decline in protection against influenza
$39,500Tara Robinson · Thomas Jefferson University · F31 · FY2007 · AG
Defining a stromal niche for type 2-like lung regulatory T cells
$39,493Anthony Chang · University Of California, San Francisco · F31 · FY2023 · HL
Comprehensive antigenic mapping of seasonal influenza viruses
$39,405Juhye Monica Lee · University Of Washington · F30 · FY2019 · AI
Investigating communication strategies of HIV discordant couples in Africa
$39,324Kathy Marie Hageman · Emory University · F31 · FY2009 · MH
SUPPLEMENTAL INFLUENZA FUNDING
$39,296Jeffrey P Engel · North Carolina St Dept/Environ, Hlth, Nr · U50 · FY2007 · CI
Novel cellular pathways that allow cells to survive influenza A virus infection
$39,264Jennifer R Hamilton · Icahn School Of Medicine At Mount Sinai · F31 · FY2017 · AI
Defining the State of CD8+ and CD4+ T cells and the Effect of Antibiotic Treatment on Chronic States of Coccidioidomycosis Disease
$39,244Susana Tejeda-Garibay · University Of California, Merced · F31 · FY2022 · HL
Screening For Inhibitors of Bacterial Capsule Biogenesis
$39,240Patrick C. Seed · Duke University · R03 · FY2010 · MH
VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL
$39,235Karen Kotloff · University Of Maryland Baltimore · N01 · FY2018 · AI
Macrophage-Mediated Lung Repair Programs Following Injury
$39,150Alan Baez Vazquez · Harvard University · F31 · FY2024 · HL
San Francisco's Plague: The View from Chinatown
$39,150Guenter B Risse · Independent Scholar- -Risse, Guenter B · G13 · FY2007 · LM
Influenza and Secondary Bacterial Pneumonia
$39,085Krishnan Chakravarthy · State University Of New York At Buffalo · F30 · FY2008 · AG
Deciphering the role of regulatory T cell derived Mmp12 in lung injury resolution
$39,023Pria Bose · Univ Of North Carolina Chapel Hill · F31 · FY2025 · HL
Antigen processing and the age-related decline in protection against influenza
$39,019Tara Robinson · Thomas Jefferson University · F31 · FY2011 · AG
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$38,988David S Stephens · Emory University · UM1 · FY2022 · AI
Loss and gain of competence in Haemophilus influenzae
$38,976Heather Maughan · University Of British Columbia · F32 · FY2007 · GM
Interrogating the Effects of Aging on Influenza Infections: The Role of Prostaglandin E2
$38,961Judy Chen · University Of Michigan At Ann Arbor · F31 · FY2022 · HL
ARRA ^ H1N1 Influenza Comparative Pathogenesis
$38,914Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI